FinTechFunding

Emyria: Receives TGA approval for Openly heart rate monitoring app

  • Emyria (EMD) has received Therapeutic Goods Administration (TGA) approval for its Openly app, which will used in several upcoming clinical trials
  • The app utilises the capabilities of a smartphone to provide medical-grade measurements of an individual’s heart rate
  • Software-based medical devices, like Apple’s HealthKit, are gaining increasing traction as verified healthcare products
  • It can now used to remotely monitor patients in clinical studies, also provide telehealth services to patients and enable other consumer healthcare products
  • The Openly app can also used to facilitate the development of other medical technologies
  • Emyria is up 0.91 per cent to $0.22 per share
Previous article
Airwallex: Secures EMI licence in the Netherlands
Next article
Maptician: Raises $1.7M in Seed Funding
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

FinTech

JPMorgan Pilots Software to Monitor Junior Bankers’ Working Hours

New initiative aims to enhance oversight of junior employee hours worked.Highlights: JPMorgan tests software to monitor working hours...
FinTech

Goldman Sachs to Implement Performance-Based Staff Cuts in April

The bank plans restructuring amidst shifting financial landscape.Highlights: Goldman Sachs plans performance-based staff cuts in April.The restructuring aims...
FinTech

Nasdaq Secures SEC Approval for Trading Tokenized Securities

This marks a significant advancement in digital asset trading.Highlights: Nasdaq gains SEC approval for trading tokenized securities.This approval...
FinTech

Aveni Launches Agentic AI Council to Enhance AI Ethics

New council aims to guide ethical AI development and deployment strategies.Highlights: Aveni establishes the Agentic AI Council for...